Angiotensin II and TGF-β1 Induce Alterations in Human Amniotic Fluid-Derived Mesenchymal Stem Cells Leading to Cardiomyogenic Differentiation Initiation

BACKGROUND AND OBJECTIVES: Human amniotic fluid-derived mesenchymal stem cells (AF-MSCs) may be a valuable source for cardiovascular tissue engineering and cell therapy. The aim of this study is to verify angiotensin II and transforming growth factor-beta 1 (TGF-β1) as potential cardiomyogenic diffe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Stem Cells
Auteurs principaux: Gasiūnienė, Monika, Petkus, Gintautas, Matuzevičius, Dalius, Navakauskas, Dalius, Navakauskienė, Rūta
Format: Artigo
Langue:Inglês
Publié: Korean Society for Stem Cell Research 2019
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657950/
https://ncbi.nlm.nih.gov/pubmed/31023001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15283/ijsc18126
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires